Author

Cassandra L. Levens

University of Colorado Anschutz

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Molecular Biology· 1 Systems Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:mouse· 2 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Assay:metabolomics· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

Kristine A. KuhniD· 2 shared Anushree ChatterjeeiD· 1 shared Catherine LozuponeiD· 1 shared Harry SmithiD· 1 shared John D. SterrettiD· 1 shared Katrina Doenges· 1 shared Kevin D. QuinniD· 1 shared Laura M. SabaiD· 1 shared

Activity by Year

2024-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersSystems Biology

Kristine A. KuhnORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Appearance of green tea compounds in plasma following acute green tea consumption is modulated by the gut microbiome in mice

John D. Sterrett, Kevin D. Quinn, Katrina Doenges, Nichole M. Nusbacher, Cassandra L. Levens, Mike L. Armstrong, Richard M. Reisdorph, Harry Smith, Laura M. Saba, Kristine A. Kuhn, Catherine Lozupone, Nichole A. Reisdorph

This study identifies green tea compounds in plasma of mice with and without gut microbiomes, showing their metabolism is influenced by microbiome composition and diversity.

Microbiology Spectrum · Jan 10, 2025Peer-reviewedSystems Biology

Microbiome- and Host Inflammasome-Targeting Inhibitor Nanoliogmers are Therapeutic in Murine Colitis Model

Sadhana Sharma, Vincenzo S. Gilberto, Cassandra L. Levens, Anushree Chatterjee, Kristine A. Kuhn, Prashant Nagpal

This paper develops and tests two Nanoligomer-based therapies, CK1 and NI112, for IBD in mice, showing reduced disease severity and biomarker expression.

bioRxiv · Feb 20, 2024 · PreprintMolecular Biology